An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Electromed, Inc. Appoints Brad Nagel as Chief Financial Officer
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Very Positive)
Tags
management
Rhea-AI Summary
Electromed, Inc. has appointed Brad Nagel as its new Chief Financial Officer, effective November 14, 2022. Nagel brings over 15 years of financial leadership experience, particularly from his role at Medtronic, where he contributed to significant revenue growth. Electromed's President, Kathleen Skarvan, expressed confidence in Nagel's ability to drive growth and create value in the company. The outgoing Interim CFO, Michelle Wirtz, will continue as Corporate Controller, ensuring leadership continuity during this transition.
Positive
Brad Nagel has over 15 years of experience in financial leadership, which could strengthen Electromed's financial strategies.
His background at Medtronic suggests potential for driving revenue growth and strategic development at Electromed.
Electromed is positioned for accelerating growth, indicating positive future prospects.
Negative
Transitioning to a new CFO may lead to temporary disruptions in financial operations or strategy.
Accomplished medical device leader to fill key strategic role
NEW PRAGUE, Minn.--(BUSINESS WIRE)--
Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that its Board of Directors has appointed Brad Nagel as the Company’s Chief Financial Officer, effective November 14, 2022.
Mr. Nagel brings to Electromed over fifteen years of financial leadership and strategic planning experience with Fortune 500 companies. Most recently, Mr. Nagel held the position of Divisional Chief Financial Officer of Global Lung Health and Visualization at Medtronic and was a key contributor in driving the unit’s revenue growth. In that role, he served as the primary business partner to the General Manager and leadership team with a strategic focus on revenue growth, expense management, strategic product development and business development. Prior to his role as Divisional Chief Financial Officer, Mr. Nagel held various roles of increasing responsibility in finance, sales operations and accounting at Medtronic, Target Corporation and TCF Bank.
“We are thrilled to welcome Brad to the Electromed team,” Kathleen Skarvan, Electromed’s President and Chief Executive Officer, commented. “Brad is a dynamic financial executive with a superior track record of engineering growth and creating value in the medical device and retail industries. Through collaborative and cross-functional leadership, Brad has proven to be a high-impact leader with extensive background in developing high-performing teams. His financial, analytical and strategic acumen coupled with his leadership style makes Brad a strong cultural fit at this time when Electromed is poised for accelerating growth. I am confident he will be an excellent addition to the leadership team.”
Skarvan continued, “I would also like to thank Michelle Wirtz for stepping into the Interim Chief Financial Officer role during our search for a permanent Chief Financial Officer. Michelle has done a tremendous job in the interim position, exemplifying the spirit and dedication of the Company, and will retain her existing role of Corporate Controller. I am grateful to have a talented and nimble team.”
Mr. Nagel stated, “I am delighted to join Electromed at a time of significant opportunity for the Company and its stakeholders. I look forward to working closely with the team to support Electromed’s growth strategies and long-term success.”
About Electromed, Inc.
Electromed, Inc. manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest® Airway Clearance System, to patients with compromised pulmonary function. The Company is headquartered in New Prague, Minnesota and was founded in 1992. Further information about the Company can be found at www.smartvest.com.
